$ACOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACORDA THERAPEUTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ACORDA THERAPEUTICS INC. Get notifications about new insider transactions in ACORDA THERAPEUTICS INC for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 17 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.76 | 600 | 17,856 | 23,500 | 24.1 K to 23.5 K (-2.49 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.76 | 300 | 8,927 | 24,100 | 24.4 K to 24.1 K (-1.23 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 8.14 | 16,000 | 130,240 | 54,109 | |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Option Exercise | M | 2.60 | 14,890 | 38,714 | 0 | |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.75 | 2,900 | 86,275 | 24,400 | 27.3 K to 24.4 K (-10.62 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.62 | 100 | 2,962 | 27,300 | 27.4 K to 27.3 K (-0.36 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.61 | 700 | 20,727 | 27,400 | 28.1 K to 27.4 K (-2.49 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.60 | 100 | 2,960 | 28,100 | 28.2 K to 28.1 K (-0.35 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.55 | 200 | 5,910 | 28,200 | 28.4 K to 28.2 K (-0.70 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.54 | 900 | 26,586 | 28,400 | 29.3 K to 28.4 K (-3.07 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.54 | 100 | 2,954 | 29,300 | 29.4 K to 29.3 K (-0.34 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.53 | 1,916 | 56,579 | 29,400 | 31.3 K to 29.4 K (-6.12 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.53 | 100 | 2,953 | 31,316 | 31.4 K to 31.3 K (-0.32 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.52 | 1,734 | 51,188 | 31,416 | 33.2 K to 31.4 K (-5.23 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.52 | 300 | 8,855 | 33,150 | 33.5 K to 33.2 K (-0.90 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.51 | 1,756 | 51,820 | 33,450 | 35.2 K to 33.5 K (-4.99 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.50 | 4,544 | 134,048 | 35,206 | 39.8 K to 35.2 K (-11.43 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.50 | 200 | 5,899 | 39,750 | 40 K to 39.8 K (-0.50 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.49 | 1,450 | 42,761 | 39,950 | 41.4 K to 40 K (-3.50 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.48 | 1,500 | 44,220 | 41,400 | 42.9 K to 41.4 K (-3.50 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.48 | 200 | 5,895 | 42,900 | 43.1 K to 42.9 K (-0.46 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.47 | 900 | 26,523 | 43,100 | 44 K to 43.1 K (-2.05 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.46 | 200 | 5,892 | 44,000 | 44.2 K to 44 K (-0.45 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.45 | 300 | 8,835 | 44,200 | 44.5 K to 44.2 K (-0.67 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.44 | 100 | 2,944 | 44,500 | 44.6 K to 44.5 K (-0.22 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.43 | 100 | 2,943 | 44,600 | 44.7 K to 44.6 K (-0.22 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.42 | 100 | 2,942 | 44,700 | 44.8 K to 44.7 K (-0.22 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.41 | 100 | 2,941 | 44,800 | 44.9 K to 44.8 K (-0.22 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.40 | 506 | 14,876 | 44,900 | 45.4 K to 44.9 K (-1.11 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 29.39 | 100 | 2,939 | 45,406 | 45.5 K to 45.4 K (-0.22 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 8.14 | 16,000 | 130,240 | 45,506 | 29.5 K to 45.5 K (+54.23 %) |
| Jun 06 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Buy | M | 2.60 | 14,890 | 38,714 | 29,506 | 14.6 K to 29.5 K (+101.87 %) |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | Greene Barry E | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | PANEM SANDRA PHD | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | PHILLIPS BARCLAY A | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | Randall Lorin | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | RAUSCHER STEVEN M | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | SMITH IAN F | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 23 2008 | ACOR | ACORDA THERAPEUTIC ... | YOUNG WISE | Director | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.00 | 500 | 9,500 | 26,164 | 26.7 K to 26.2 K (-1.88 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.05 | 800 | 15,240 | 26,664 | 27.5 K to 26.7 K (-2.91 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.10 | 400 | 7,640 | 27,464 | 27.9 K to 27.5 K (-1.44 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.15 | 300 | 5,745 | 27,864 | 28.2 K to 27.9 K (-1.07 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.20 | 200 | 3,840 | 28,164 | 28.4 K to 28.2 K (-0.71 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Wasman Jane | Exec VP, General Co ... | Sell | S | 19.45 | 225 | 4,376 | 28,364 | 28.6 K to 28.4 K (-0.79 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.42 | 400 | 7,768 | 157,384 | 157.8 K to 157.4 K (-0.25 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.44 | 200 | 3,888 | 157,784 | 158 K to 157.8 K (-0.13 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.45 | 200 | 3,890 | 157,984 | 158.2 K to 158 K (-0.13 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.46 | 300 | 5,838 | 158,184 | 158.5 K to 158.2 K (-0.19 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.47 | 857 | 16,686 | 158,484 | 159.3 K to 158.5 K (-0.54 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.48 | 300 | 5,844 | 159,341 | 159.6 K to 159.3 K (-0.19 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.50 | 1,600 | 31,200 | 159,641 | 161.2 K to 159.6 K (-0.99 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.51 | 600 | 11,706 | 161,241 | 161.8 K to 161.2 K (-0.37 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.52 | 300 | 5,856 | 161,841 | 162.1 K to 161.8 K (-0.19 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.53 | 1,600 | 31,248 | 162,141 | 163.7 K to 162.1 K (-0.98 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.54 | 400 | 7,816 | 163,741 | 164.1 K to 163.7 K (-0.24 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.55 | 800 | 15,640 | 164,141 | 164.9 K to 164.1 K (-0.49 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.56 | 900 | 17,604 | 164,941 | 165.8 K to 164.9 K (-0.54 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.57 | 100 | 1,957 | 165,841 | 165.9 K to 165.8 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.58 | 400 | 7,832 | 165,941 | 166.3 K to 165.9 K (-0.24 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.59 | 500 | 9,795 | 166,341 | 166.8 K to 166.3 K (-0.30 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.60 | 543 | 10,643 | 166,841 | 167.4 K to 166.8 K (-0.32 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.61 | 200 | 3,922 | 167,384 | 167.6 K to 167.4 K (-0.12 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.62 | 600 | 11,772 | 167,584 | 168.2 K to 167.6 K (-0.36 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.63 | 881 | 17,294 | 168,184 | 169.1 K to 168.2 K (-0.52 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.64 | 700 | 13,748 | 169,065 | 169.8 K to 169.1 K (-0.41 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.65 | 1,200 | 23,580 | 169,765 | 171 K to 169.8 K (-0.70 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.66 | 600 | 11,796 | 170,965 | 171.6 K to 171 K (-0.35 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.67 | 519 | 10,209 | 171,565 | 172.1 K to 171.6 K (-0.30 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.68 | 1,200 | 23,616 | 172,084 | 173.3 K to 172.1 K (-0.69 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.69 | 100 | 1,969 | 173,284 | 173.4 K to 173.3 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.70 | 800 | 15,760 | 173,384 | 174.2 K to 173.4 K (-0.46 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.71 | 232 | 4,573 | 174,184 | 174.4 K to 174.2 K (-0.13 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.72 | 500 | 9,860 | 174,416 | 174.9 K to 174.4 K (-0.29 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.73 | 100 | 1,973 | 174,916 | 175 K to 174.9 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 5,000 | 13,000 | 556,131 | |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 4,808 | 12,501 | 0 | |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Option Exercise | M | 2.60 | 21,624 | 56,222 | 10 | |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.74 | 200 | 3,948 | 175,016 | 175.2 K to 175 K (-0.11 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.75 | 100 | 1,975 | 175,216 | 175.3 K to 175.2 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.76 | 1,301 | 25,708 | 175,316 | 176.6 K to 175.3 K (-0.74 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.78 | 99 | 1,958 | 176,617 | 176.7 K to 176.6 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.79 | 200 | 3,958 | 176,716 | 176.9 K to 176.7 K (-0.11 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.85 | 200 | 3,970 | 176,916 | 177.1 K to 176.9 K (-0.11 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.87 | 200 | 3,974 | 177,116 | 177.3 K to 177.1 K (-0.11 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.88 | 400 | 7,952 | 177,316 | 177.7 K to 177.3 K (-0.23 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.89 | 300 | 5,967 | 177,716 | 178 K to 177.7 K (-0.17 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.90 | 240 | 4,776 | 178,016 | 178.3 K to 178 K (-0.13 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.91 | 300 | 5,973 | 178,256 | 178.6 K to 178.3 K (-0.17 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.92 | 100 | 1,992 | 178,556 | 178.7 K to 178.6 K (-0.06 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.93 | 860 | 17,140 | 178,656 | 179.5 K to 178.7 K (-0.48 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.94 | 600 | 11,964 | 179,516 | 180.1 K to 179.5 K (-0.33 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.95 | 400 | 7,980 | 180,116 | 180.5 K to 180.1 K (-0.22 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.96 | 300 | 5,988 | 180,516 | 180.8 K to 180.5 K (-0.17 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.97 | 300 | 5,991 | 180,816 | 181.1 K to 180.8 K (-0.17 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.98 | 400 | 7,992 | 181,116 | 181.5 K to 181.1 K (-0.22 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 19.99 | 500 | 9,995 | 181,516 | 182 K to 181.5 K (-0.27 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.00 | 1,100 | 22,000 | 182,016 | 183.1 K to 182 K (-0.60 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.01 | 1,900 | 38,019 | 183,116 | 185 K to 183.1 K (-1.03 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.02 | 1,000 | 20,020 | 185,016 | 186 K to 185 K (-0.54 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.03 | 1,000 | 20,030 | 186,016 | 187 K to 186 K (-0.53 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.04 | 700 | 14,028 | 187,016 | 187.7 K to 187 K (-0.37 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.05 | 200 | 4,010 | 187,716 | 187.9 K to 187.7 K (-0.11 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.06 | 600 | 12,036 | 187,916 | 188.5 K to 187.9 K (-0.32 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.07 | 100 | 2,007 | 188,516 | 188.6 K to 188.5 K (-0.05 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.08 | 100 | 2,008 | 188,616 | 188.7 K to 188.6 K (-0.05 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 20.11 | 100 | 2,011 | 188,716 | 188.8 K to 188.7 K (-0.05 %) |
| May 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Buy | M | 2.60 | 31,432 | 81,723 | 188,816 | 157.4 K to 188.8 K (+19.97 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.29 | 500 | 9,145 | 29,315 | 29.8 K to 29.3 K (-1.68 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.30 | 272 | 4,978 | 29,815 | 30.1 K to 29.8 K (-0.90 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.34 | 1,300 | 23,842 | 30,087 | 31.4 K to 30.1 K (-4.14 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.35 | 514 | 9,432 | 31,387 | 31.9 K to 31.4 K (-1.61 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.36 | 100 | 1,836 | 31,901 | 32 K to 31.9 K (-0.31 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.43 | 386 | 7,114 | 32,001 | 32.4 K to 32 K (-1.19 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.44 | 228 | 4,204 | 32,387 | 32.6 K to 32.4 K (-0.70 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.45 | 185 | 3,413 | 32,615 | 32.8 K to 32.6 K (-0.56 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.47 | 100 | 1,847 | 32,800 | 32.9 K to 32.8 K (-0.30 %) |
| Apr 09 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.49 | 1 | 18 | 32,900 | 32.9 K to 32.9 K (0.00 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.45 | 200 | 3,490 | 32,901 | 33.1 K to 32.9 K (-0.60 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.50 | 200 | 3,500 | 33,101 | 33.3 K to 33.1 K (-0.60 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.52 | 300 | 5,256 | 33,301 | 33.6 K to 33.3 K (-0.89 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.55 | 200 | 3,510 | 33,601 | 33.8 K to 33.6 K (-0.59 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.56 | 200 | 3,512 | 33,801 | 34 K to 33.8 K (-0.59 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.66 | 100 | 1,766 | 34,001 | 34.1 K to 34 K (-0.29 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.67 | 200 | 3,534 | 34,101 | 34.3 K to 34.1 K (-0.58 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.77 | 200 | 3,554 | 34,301 | 34.5 K to 34.3 K (-0.58 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.85 | 150 | 2,678 | 34,501 | 34.7 K to 34.5 K (-0.43 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.86 | 50 | 893 | 34,651 | 34.7 K to 34.7 K (-0.14 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.93 | 400 | 7,172 | 34,701 | 35.1 K to 34.7 K (-1.14 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 17.96 | 200 | 3,592 | 35,101 | 35.3 K to 35.1 K (-0.57 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.00 | 200 | 3,600 | 35,301 | 35.5 K to 35.3 K (-0.56 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.13 | 200 | 3,626 | 35,501 | 35.7 K to 35.5 K (-0.56 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.15 | 200 | 3,630 | 35,701 | 35.9 K to 35.7 K (-0.56 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.27 | 600 | 10,962 | 35,901 | 36.5 K to 35.9 K (-1.64 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.48 | 200 | 3,696 | 36,501 | 36.7 K to 36.5 K (-0.54 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.64 | 129 | 2,405 | 36,701 | 36.8 K to 36.7 K (-0.35 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | Blight Andrew | Chief Scientific Of ... | Sell | S | 18.65 | 71 | 1,324 | 36,830 | 36.9 K to 36.8 K (-0.19 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.22 | 200 | 3,444 | 14,616 | 14.8 K to 14.6 K (-1.35 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.25 | 400 | 6,900 | 14,816 | 15.2 K to 14.8 K (-2.63 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.26 | 200 | 3,452 | 15,216 | 15.4 K to 15.2 K (-1.30 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.30 | 600 | 10,380 | 15,416 | 16 K to 15.4 K (-3.75 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.36 | 200 | 3,472 | 16,016 | 16.2 K to 16 K (-1.23 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | LAWRENCE DAVID | Chief Financial Off ... | Sell | S | 17.66 | 200 | 3,532 | 16,216 | 16.4 K to 16.2 K (-1.22 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.45 | 200 | 3,490 | 157,384 | 157.6 K to 157.4 K (-0.13 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.50 | 100 | 1,750 | 157,584 | 157.7 K to 157.6 K (-0.06 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.51 | 200 | 3,502 | 157,684 | 157.9 K to 157.7 K (-0.13 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.52 | 300 | 5,256 | 157,884 | 158.2 K to 157.9 K (-0.19 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.55 | 200 | 3,510 | 158,184 | 158.4 K to 158.2 K (-0.13 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.56 | 100 | 1,756 | 158,384 | 158.5 K to 158.4 K (-0.06 %) |
| Mar 12 2008 | ACOR | ACORDA THERAPEUTIC ... | COHEN RON | President and CEO | Sell | S | 17.57 | 300 | 5,271 | 158,484 | 158.8 K to 158.5 K (-0.19 %) |